Olivera, G.G.; Urtasun, A.; Sendra, L.; Aliño, S.F.; Yáñez, Y.; Segura, V.; Gargallo, P.; Berlanga, P.; Castel, V.; Cañete, A.;
et al. Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next? Int. J. Mol. Sci. 2021, 22, 9815.
https://doi.org/10.3390/ijms22189815
AMA Style
Olivera GG, Urtasun A, Sendra L, Aliño SF, Yáñez Y, Segura V, Gargallo P, Berlanga P, Castel V, Cañete A,
et al. Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next? International Journal of Molecular Sciences. 2021; 22(18):9815.
https://doi.org/10.3390/ijms22189815
Chicago/Turabian Style
Olivera, Gladys G., Andrea Urtasun, Luis Sendra, Salvador F. Aliño, Yania Yáñez, Vanessa Segura, Pablo Gargallo, Pablo Berlanga, Victoria Castel, Adela Cañete,
and et al. 2021. "Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?" International Journal of Molecular Sciences 22, no. 18: 9815.
https://doi.org/10.3390/ijms22189815
APA Style
Olivera, G. G., Urtasun, A., Sendra, L., Aliño, S. F., Yáñez, Y., Segura, V., Gargallo, P., Berlanga, P., Castel, V., Cañete, A., & Herrero, M. J.
(2021). Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next? International Journal of Molecular Sciences, 22(18), 9815.
https://doi.org/10.3390/ijms22189815